نتائج البحث

Reducing Flow Resistance via Introduction and Enlargement of Microcracks in Convection Enhanced Delivery (CED) in Porous Tumors

• Authors : Md Jawed Naseem; Ronghui Ma; Liang Zhu

Subjects: drug delivery; porous tumors; convection-enhanced delivery (CED)

• Source: Fluids, Vol 9, Iss 9, p 215 (2024)

تفاصيل العنوان

Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma

• Source: An Open-Label Non-Randomized, Multi-Center Phase-2 Study of Convection-Enhanced Delivery (

تفاصيل العنوان

Topotecan Using Convection-Enhanced Delivery (CED) in High Grade Glioma

• Authors : Infuseon Therapeutics, Inc.; Michael Vogelbaum, MD, PhD, Principal Investigator

• Source: A Pilot Trial of Intraparenchymally-Administered Topotecan Using Convection-Enhanced Delivery (

تفاصيل العنوان

SURG-07. A PHASE I STUDY EXAMINING THE FEASIBILITY OF INTERMITTENT CONVECTION-ENHANCED DELIVERY (CED) OF MTX110 FOR THE TREATMENT OF CHILDREN WITH NEWLY DIAGNOSED DIFFUSE MIDLINE GLIOMAS

• Authors : Szalontay, Luca; CreveCoeur, Travis; Neira, Justin

• Source: Neuro-Oncology ; volume 26, issue Supplement_4, page 0-0 ; ISSN 1522-8517 1523-5866

تفاصيل العنوان

CTNI-50. UPDATE REPORT OF THE RESPECT-GBM PHASE I/IIA DOSE ESCALATION TRIAL OF RHENIUM-186 NANOLIPOSOME (186RNL) IN RECURRENT GLIOMA [RGBM] VIA CONVECTION ENHANCED DELIVERY (CED)

• Authors : Brenner, Andrew; Michalek, Joel; Moore, Melissa

• Source: Neuro-Oncology ; volume 25, issue Supplement_5, page v86-v86 ; ISSN 1522-8517 1523-5866

تفاصيل العنوان

CTIM-09. PHASE 1/1B TRIAL OF FC-ENGINEERED ANTI-CD40 AGONIST MONOCLONAL ANTIBODY (2141-V11) INFUSED WITH D2C7-IT IN ENHANCING DISEASE BY CONVECTION-ENHANCED DELIVERY (CED) FOR RECURRENT MALIGNANT GLIOMA (RMG)

• Authors : Desjardins, Annick; Chandramohan, Vidya; Landi, Daniel

• Source: Neuro-Oncology ; volume 25, issue Supplement_5, page v62-v63 ; ISSN 1522-8517 1523-5866

تفاصيل العنوان

DDEL-07. A Phase I study examining the feasibility of intermittent convection-enhanced delivery (CED) of MTX110 for the treatment of children with newly diagnosed diffuse midline gliomas (DMGs)

• Authors : Zacharoulis, Stergios; Szalontay, Luca; CreveCoeur, Travis

• Source: Neuro-Oncology ; volume 24, issue Supplement_1, page i35-i35 ; ISSN 1522-8517 1523-5866

تفاصيل العنوان

RADT-20. REPORT OF THE RESPECT-GBM™ PHASE I/IIA DOSE ESCALATION TRIAL OF RHENIUM-186 NANOLIPOSOME (186RNL) IN RECURRENT GLIOMA VIA CONVECTION ENHANCED DELIVERY (CED) & PLANNED PHASE IIB TRIAL

• Authors : Brenner, Andrew; Phillips, William; Bao, Ande

• Source: Neuro-Oncology ; volume 24, issue Supplement_7, page vii53-vii53 ; ISSN 1522-8517 1523-5866

تفاصيل العنوان

CTIM-23. DOSE ESCALATION TRIAL OF FC-ENGINEERED ANTI-CD40 MONOCLONAL ANTIBODY (2141-V11) ADMINISTERED INTRATUMORALLY WITH D2C7-IT VIA CONVECTION-ENHANCED DELIVERY (CED) FOR RECURRENT MALIGNANT GLIOMAS (RMGS)

• Authors : Desjardins, Annick; Chandramohan, Vidya; Landi, Daniel

• Source: Neuro-Oncology ; volume 24, issue Supplement_7, page vii65-vii65 ; ISSN 1522-8517 1523-5866

تفاصيل العنوان

DIPG-53. Long-term survival from a Phase 1 dose-escalation trial using convection-enhanced delivery (CED) of radioimmunotherapeutic124I-omburtamab for treatment of diffuse intrinsic pontine glioma (DIPG).

• Authors : Souweidane, Mark M; Kramer, Kim; Pandit-Tasker, Neeta

• Source: Neuro-Oncology ; volume 24, issue Supplement_1, page i30-i31 ; ISSN 1522-8517 1523-5866

تفاصيل العنوان